- Home
- BBIO vs IRT Comparison
BBIO vs IRT Comparison
Compare BBIO & IRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- IRT
- Stock Information
- Founded
- BBIO 2015
- IRT 2009
- Country
- BBIO United States
- IRT United States
- Employees
- BBIO N/A
- IRT 952
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- IRT Real Estate Investment Trusts
- Sector
- BBIO Health Care
- IRT Real Estate
- Exchange
- BBIO Nasdaq
- IRT Nasdaq
- Market Cap
- BBIO 5.1B
- IRT 4.5B
- IPO Year
- BBIO 2019
- IRT 2013
- Fundamental
- Price
- BBIO $26.49
- IRT $20.29
- Analyst Decision
- BBIO Strong Buy
- IRT Buy
- Analyst Count
- BBIO 13
- IRT 9
- Target Price
- BBIO $47.92
- IRT $20.33
- AVG Volume (30 Days)
- BBIO 2.7M
- IRT 1.8M
- Earning Date
- BBIO 11-12-2024
- IRT 02-12-2025
- Dividend Yield
- BBIO N/A
- IRT 3.17%
- EPS Growth
- BBIO N/A
- IRT N/A
- EPS
- BBIO N/A
- IRT N/A
- Revenue
- BBIO $217,765,000.00
- IRT $641,630,000.00
- Revenue This Year
- BBIO $2,648.47
- IRT N/A
- Revenue Next Year
- BBIO N/A
- IRT $5.01
- P/E Ratio
- BBIO N/A
- IRT N/A
- Revenue Growth
- BBIO 2209.77
- IRT N/A
- 52 Week Low
- BBIO $21.62
- IRT $14.08
- 52 Week High
- BBIO $44.32
- IRT $22.26
- Technical
- Relative Strength Index (RSI)
- BBIO 49.05
- IRT 34.99
- Support Level
- BBIO $25.34
- IRT $21.18
- Resistance Level
- BBIO $28.15
- IRT $21.89
- Average True Range (ATR)
- BBIO 1.33
- IRT 0.45
- MACD
- BBIO -0.24
- IRT -0.22
- Stochastic Oscillator
- BBIO 24.73
- IRT 18.45
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.